dr abdullah alshaya pediatric endocrinologist

85
Type I DM in Type I DM in Pediatric Pediatric Dr Abdullah Alshaya Pediatric Endocrinologist

Upload: geoffrey-adams

Post on 18-Jan-2018

256 views

Category:

Documents


0 download

DESCRIPTION

Introduction Insulin regimen Insulin dose Diet Monitoring Hypoglycemia Management during infection Screening for chronic complication

TRANSCRIPT

Page 1: Dr Abdullah Alshaya Pediatric Endocrinologist

Type I DM in Type I DM in PediatricPediatric

Dr Abdullah AlshayaPediatric Endocrinologist

Page 2: Dr Abdullah Alshaya Pediatric Endocrinologist

• Introduction• Insulin regimen• Insulin dose• Diet• Monitoring• Hypoglycemia• Management during infection• Screening for chronic complication

Page 3: Dr Abdullah Alshaya Pediatric Endocrinologist

DIAGNOSTIC CRITERIA FOR IMPAIRED GLUCOSE TOLERANCE AND DIABETES

MELLITUS

Page 4: Dr Abdullah Alshaya Pediatric Endocrinologist

Diagnostic Criteria of Impaired Glucose Tolerance and Diabetes Mellitus Table

Symptoms include polyuria, polydipsia, and unexplained weight loss with glucosuria and ketonuria. A fasting glucose concentration of 99 mg/dL is the upper limit of “normal”.

Page 5: Dr Abdullah Alshaya Pediatric Endocrinologist

Etiologic Classification of Diabetes Mellitus Table

Page 6: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 7: Dr Abdullah Alshaya Pediatric Endocrinologist

Classification of DiabetesType I DMType I DM Type II DMType II DM

Aetiology Autoimmune (- cell destruction)

Insulin resistance and -cell dysfunction

Peak age 12 years 60 years

Prevalence 0.3% 6% (>10% above 60 years)

Presentation Osmotic symptoms, weight loss (days to weeks), DKAPatient usually slim

Osmotic symptoms, diabetic complications (months to years).Patient usually obese

Treatment Diet and insulin Diet, exercise (weight loss), oral hypoglycemics, Insulin later

Page 8: Dr Abdullah Alshaya Pediatric Endocrinologist

Epidemiology:

The incidence among school-age children is about 1.9/ 1,000 in USA with annual incidence about 14.9 new cases/ 100,000 children.

• Sex: M:F ratio is 1:1.• Age at presentation: Peaks occur in 2 age

groups. At 5-7 yr of age and puberty

• Seasonal variations: More frequent in the autumn and winter months.

Page 9: Dr Abdullah Alshaya Pediatric Endocrinologist

Etiology:

The Mechanisms that lead to failure of

pancreatic ß-cell function increasingly point

to an auto immune destruction ofpancreatic islet ß cells in

predisposed individuals.

Page 10: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

1. Type 1 DM is commonly associated with auto immune diseases as celiac disease, Addison disease, and thyroiditis.

2. Auto antibodies as (GAD)and islet cell cytoplasm antibodies (ICA) and insulin auto antibodies (IAA) are detected in the sera of newly diagnosed patients.

Page 11: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

3. Genetic predisposition (the increased protection and susceptibility to T1DM)

The Genetics of type 1 DM cannot be classified according to a specific model of inheritances. The most important genes are located within the MHC HLA class II region on chromosome 6p21, accounting for about 60% of genetic susceptibility for the disease.

Page 12: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

4. EnvironmentFactors such as viral infections, chemicals, seasonal factors, and dietary factors have been suspected of contributing to differences in the incidence and prevalence of type 1 DM in various ethnic populations.

Page 13: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

a. Viral Infections: A variety of viruses and mechanisms may contribute to the development of T1DM in genetically susceptible hosts. Enteroviral, congenital rubella, and mumps infection leads to the development of ß-cell auto immunity with high frequency and to T1DM in some cases. Congenital rubella infection is associated with diabetes (up to 40%).

Page 14: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

b. Diet

• Breast-feedingMay lower the risk of T1DM, either directly or by delaying exposure to cow’s milk protein.

Page 15: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

• Early introduction of cow’s milk protein and early exposure to gluten in cereals have both been implicated in the development of auto immunity and it has been suggested that this is due to the “leakiness” of the immature gut to protein antigen

• s. Antigens that have been implicated include ß-lactoglobulin, which is homologous to the human protein glycodelin (PP14), a T-cell modulator. Other studies have focused on bovine serum abumin as the inciting antigen,.

Page 16: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

• Other dietary factors that have been suggested at various times as playing a role in diabetes risk include Omega-3 fatty acids, Vitamin D, ascorbic acid, zinc, and Vitamin E

• Vitamin D has a role in immune regulation, decreased Vitamin D levels in pregnancy or early childhood may be associated with diabetes risk; but the evidence is not yet conclusive.

Page 17: Dr Abdullah Alshaya Pediatric Endocrinologist

Evidences supporting the auto immune basis of type 1 DM (T1DM)

c. Psychologic stress: Several studies show an increased prevalence of stressful psychologic situations among children who subsequently developed T1DM. Whether these stresses only aggravate pre-existing auto immunity or whether they can actually trigger auto immunity remains unknown.

Page 18: Dr Abdullah Alshaya Pediatric Endocrinologist

Pathogenesis and natural history of type 1 diabetes mellitus

A genetically susceptible host develops auto immunity against his or her own ß cells. What triggers this auto immune response remains unclear at this time. In some ( But not all) patients, this auto immune process results in progressive destruction of ß cells until a critical mass of ß cells are destroyed and the patient becomes totally dependent on exogenous insulin for survival.

Page 19: Dr Abdullah Alshaya Pediatric Endocrinologist

Pathogenesis and natural history of type 1 diabetes mellitus

1.Initiation of auto immunity.2. Preclinical auto immunity with progressive loss of ß-cell function.3. Onset of clinical disease.4. Transient remission (honeymoon period).5. Established disease.6. Development of complications.

Page 20: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 21: Dr Abdullah Alshaya Pediatric Endocrinologist

Pathophysiology

In normal individuals, there are normal swings between the postprandial, high-insulin anabolic state and fasted, low-insulin catabolic state that affect 3 major tissues: liver, muscle, and adipose tissue.

Page 22: Dr Abdullah Alshaya Pediatric Endocrinologist

Influence of feeding (High Insulin) or of fasting (Low Insulin) on some Metabolic processes in liver, muscles and adipose tissue.

Tissue Postprandial State(High Plasma

Insulin)

Fasted State(Low Plasma

Insulin)Liver • Glucose uptake,

glycogen synthesis, absence of gluconeogenesis• Lipogenesis• Absence of ketogenesis

• Glucose production (glycogenolysis + gluconeogenesis)• Absence of lipogenesis• Ketogenesis

Muscle • Glucose uptake and oxidation, and glycogen synthesis• Protein synthesis

• Absence of glucose uptake• Glycogenolysis•Proteolysis and amino acid release

Adipose Tissue

• Glucose uptake• Triglyceride uptake• Lipid synthesis

• Absence of glucose uptake•Absence of triglyceride uptake• Lipolysis and fatty acids release

Page 23: Dr Abdullah Alshaya Pediatric Endocrinologist

1. Hyperglycemia- (fasting and increases after eating): due to glucose production (glycogenolysis and gluconeogenesis) and absence of glucose uptake by muscle and adipose tissues.

Page 24: Dr Abdullah Alshaya Pediatric Endocrinologist

2. Glucosuria - When blood glucose level exceeds the renal tubular maximum (Tm) of glucose (180 mg/dL). Calories are lost in urine a compensatory hyperphagia. If the Hyperphagia does not keep pace with the glucosuria, loss of body fat ensues with clinicalweight loss.

Page 25: Dr Abdullah Alshaya Pediatric Endocrinologist

Influence of feeding (High Insulin) or of fasting (Low Insulin) on some Metabolic processes in liver, muscles and adipose tissue.

3. Metabolic Acidosis- Insulinopenia, diminished energy production from glucose lipolysis. Peripheral utilization of fatty acids is incomplete and they are converted to ketone bodies in the liver. Accumulation of ketoacids (acetoacetic, ß-hydroxybutyric acids) will lead to metabolic acedosis. Ketoacidosis leads Kussmaul respiration (deep rapid breathing), fruity breath odor (acetone), diminished neurocognitive function, and possible coma.

Page 26: Dr Abdullah Alshaya Pediatric Endocrinologist

4. Dehydration and loss of electrolytes Ketones in association with cations are excreted in urine- loss of fluid and electrolytes, also hyperglycemia will lead to osmotic diuresis.

Page 27: Dr Abdullah Alshaya Pediatric Endocrinologist

5. Hyperosmolality - It is due to dehydration and hyperglycemia.Serum osmolality in mOsm/kg=2 (serum Na) glucose mg/ dL /18 + BUN mg/ dL /3.

Page 28: Dr Abdullah Alshaya Pediatric Endocrinologist

• 6. Impaired level of consciousness- it is due to dehydration, hyperosmolality, metabolic acidosis, and diminished cerebral oxygen utilization.

Page 29: Dr Abdullah Alshaya Pediatric Endocrinologist

Clinical Manifestations

Different clinical presentations

1. The classic presentation of diabetes in children is a history of polyuria, polydipsia, hyperphagia, and loss of weight (loss of body fat). The duration of these symptoms is often less than 1 mo. Hyperphagia occurs as a compensatory mechanism when calories are lost in the urine (glucosuria).

Page 30: Dr Abdullah Alshaya Pediatric Endocrinologist

Clinical Manifestations

2. Enuresis (due to polyuria) in a previously

toilet-trained child.

3. Insidious onset with lethargy, weakness,

and weight loss (in spite of an increased Apetite).

4. Pyogenic skin infections or monolial vaginitis ( in teenage girls due to chronic glucosuria).

Page 31: Dr Abdullah Alshaya Pediatric Endocrinologist

Clinical Manifestations

5. Diabetic ketoacido sis- it is the clinical presentation of 20%-40% of new-onset diabetic children and in children with known diabetes who omit insulin doses or who do not successfully manage the precipitating factors (trauma, infection, vomiting, and psychologic disturbances).

Page 32: Dr Abdullah Alshaya Pediatric Endocrinologist

Clinical Manifestations

• The early manifestations may be mild (nausea, vomiting, polyuria and dehydration).

• Kussmaul respiration (deep rapid respiration due to metabolic acidosis in an attempt to excrete excess CO2) with an odor of acetone on the breath (acetone is formed by non enzymatic conversion of acetoacetate).

Page 33: Dr Abdullah Alshaya Pediatric Endocrinologist

Clinical Manifestations

• Abdominal pain or rigidity (DD: appendicitis, pancreatitis), nausea, and emesis.

• Severe dehydration • Cerebral obtundation and ultimately

coma.

Page 34: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 35: Dr Abdullah Alshaya Pediatric Endocrinologist

Diagnosis of T1DM

1. Hyperglycemia- Non fasting blood glucose value exceeding 200 mg/ dL with typical symptoms.

2. Glucosuria

Page 36: Dr Abdullah Alshaya Pediatric Endocrinologist

DDThe differential diagnosis of diabetes mellitus is not difficult, since this is virtually the only condition that gives rise to hyperglycemia, glucosuria and ketosis.

. Renal glucosuria

Isolated Congenital disorder.

Renal tubular disorder (Fanconi syndrome, Renal disorders due to intoxication by heavy metals {lead} or outdated tetracycline or inborn errors of metabolism {cystinosis}).

Page 37: Dr Abdullah Alshaya Pediatric Endocrinologist

DD

. Causes of metabolic acidosis

Uremia, gastroenteritis with metabolic acidosis, hypoglycemia, lactic acidosis, salicylate intoxication, sepsis and encephalitis.

. Physical stress

Transient hyperglycemia with glucosuria, this is induced by counter regulatory hormones.

Page 38: Dr Abdullah Alshaya Pediatric Endocrinologist

New-Onset Diabetes without Ketoacidosis

• Excellent diabetes control involves many goals• to maintain a balance between tight glucose control

and avoiding hypoglycemia• to eliminate polyuria and nocturia, to prevent

ketoacidosis• permit normal growth and development with minimal

effect on lifestyle.

initiation and adjustment of insulin,• extensive teaching of the child and caretakers• reestablishment of the life routines.

Page 39: Dr Abdullah Alshaya Pediatric Endocrinologist

• Each aspect should be addressed early in the overall care.

• therapy can begin in the outpatient setting, with complete team staffing by a pediatric endocrinologist, experienced nursing staff, dietitians with training as diabetes educators, and a social worker.

• Close contact between the diabetes team and family

must be assured. Otherwise, initial therapy should be

done in the hospital setting.

Page 40: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 41: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 42: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 43: Dr Abdullah Alshaya Pediatric Endocrinologist

Types of InsulinTypes of Insulin• Rapid Acting:

– Insulin lispro (Humalog) ®

– Insulin aspart (Novolog) ®

– Insulin glulisine (Apidra) ®

• Short-acting:

– Regular

• Intermediate-acting:

– NPH

• Long-acting:

– Insulin glargine (Lantus) ®

– Insulin detemir (Levemir) ®

– Insulin degludec (tresiba)

Page 44: Dr Abdullah Alshaya Pediatric Endocrinologist

Rapid (lispro, aspart, glulisine)

Hours

Long (glargine)

Short (regular)

Intermediate (NPH)

Long (detemir)

InsulinLevel

0 2 4 6 8 10 12 14 16 18 20 22 24

Pharmacokinetics of Insulin ProductsPharmacokinetics of Insulin Products

Adapted from Hirsch I. N Engl J Med. 2005;352:174-183.

Page 45: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 46: Dr Abdullah Alshaya Pediatric Endocrinologist

Normal Insulin SecretionNormal Insulin Secretion

Basal (background) insulin needs0

10

20

30

40

50

0 2 4 6 8 10 12 14 16 18 20 22 24

Seru

m in

sulin

(µU

/mL)

Time

Meal Meal Meal Bolus (meal) insulin needs

60

Page 47: Dr Abdullah Alshaya Pediatric Endocrinologist

Common Insulin Regimens• The goal of treatment in type 1 DM is to provide

insulin in as physiologic a manner as possible.• Insulin replacement is accomplished by giving a basal

insulin and a preprandial (premeal) insulin• The basal insulin is either long-acting (glargine or

detemir • The preprandial insulin is either rapid-acting (lispro,

aspart, or glulisine) or short-acting (regular)

Page 48: Dr Abdullah Alshaya Pediatric Endocrinologist

• For patients on intensive insulin regimens (multiple daily

injections or insulin pumps), the preprandial dose is based on the

carbohydrate content of the meal (the carbohydrate ratio)

• plus a correction dose if their blood glucose level is elevated

• This method allows patients more flexibility in caloric intake and

activity, but it requires more blood glucose monitoring and

closer attention to the control of their diabetes.

Page 49: Dr Abdullah Alshaya Pediatric Endocrinologist

4:00 16:00 20:00 24:00 4:00

Breakfast Lunch Dinner

8:0012:008:00

Glargine or detemir

Plas

ma

insu

linBasal/Bolus Treatment Program With Rapid-

Acting and Long-Acting Analogs

Bed

Rapid (lispro, aspart, glulisine)

Rapid (lispro, aspart, glulisine)

Rapid (lispro, aspart, glulisine)

Page 50: Dr Abdullah Alshaya Pediatric Endocrinologist

Subcutaneous Insulin Dosing

Age (years)

0-5

5-12

12-18

Target Glucose (mg/dL)

100-200

80-150

80-130

Target Daily Insulin (units/kg/d)

0.6-0.7

0.7-1.0

1.0-1.2

Basal Insulin (% of total daily dose)

25-30

40-50

40-50

Bolus Units added per 100 mg/dL above target

Insulin Units Added per 15 g at Meal

0.5 0.5

0.75 0.75

1.0-2.0 1.0-2.0

Page 51: Dr Abdullah Alshaya Pediatric Endocrinologist

Newly diagnosed children in the “honeymoon” may only

need 60-70% of a full replacement dose. Total daily dose

per kg increases with puberty.

Newly diagnosed children who do not use carbohydrate

dosing should divide the nonbasal portion of the daily

insulin dose into equal doses for each meal

Page 52: Dr Abdullah Alshaya Pediatric Endocrinologist

Indeed, bolus-basal treatment with multiple injections is better adapted to the physiologic profiles of insulin and glucose and can therefore provide better glycemic control than the conventional two-to-three dose regimen. This approach allows insulin doses to be changed as needed to correct hyperglycemia, supplement for additional anticipated carbohydrate intake, or subtract for exercise.

Page 53: Dr Abdullah Alshaya Pediatric Endocrinologist

Some families may be unable to administer four daily injections. In these cases, a compromise may be needed:

A three-injection regimen: Combining NPH with a rapid analog bolus at breakfast, a rapid acting analog bolus at supper, and NPH at bed time. This regimen may provide fair glucose control.

A two-injection regimen: This would require NPH combined with a rapid analog bolus at breakfast and supper. However, such a schedule would provide poor coverage for lunch and early morning, and would increase the risk of hypo glycemia at midmorning and early night.

Page 54: Dr Abdullah Alshaya Pediatric Endocrinologist

a. The total daily insulin requirement is calculated.

b. 2/3 of the daily dose is given before breakfast and 1/3

before supper (if the total dose is 30 U, 20 U will be given

before breakfast and 10 U before supper).

c. Each injection consists of intermediate and regular insulins

in proportions of 2: 1 or 3:1 (20 U before breakfast =14U of

NPH + 6 U of regular insulin, and 10 U before supper= 6 U of

NPH + 4 U of regular insulin).

Page 55: Dr Abdullah Alshaya Pediatric Endocrinologist

Fine Adjustment of the Two Injection Fine Adjustment of the Two Injection RegimenRegimen

Page 56: Dr Abdullah Alshaya Pediatric Endocrinologist

INSULIN DOSAGEINSULIN DOSAGEInsulin requirement is based upon the body weight, age, and pubertal stage of the child

In general, the newly diagnosed child requires an initial total daily insulin dose of 0.5 to 1.0 units/kg.

Prepubertal children usually require lower doses, and the dose requirement may be as low as 0.25 units/kg for a variable period following diagnosis.

Higher doses are needed in pubertal children, patients in ketoacidosis, or in patients receiving glucocorticoid therapy.

Page 57: Dr Abdullah Alshaya Pediatric Endocrinologist

INSULIN DOSAGEINSULIN DOSAGEIn infants and toddlers who receive their insulin by syringe, the insulin dose may be so small that dilution is required to allow for easier and more precise administration.

The smallest dose of insulin that can be accurately administered without dilution using a syringe is 0.5 units.

Many insulins can be diluted either at a specialized pharmacy or at home with proper training.

Specific diluent for many insulin preparations is available from the insulin manufacturer.

Some insulin pumps can deliver much smaller doses of insulin, of the order of 0.025 units at a time, often obviating this problem.

Page 58: Dr Abdullah Alshaya Pediatric Endocrinologist

INSULIN DOSAGEINSULIN DOSAGE

On average, 1 unit of insulin is required to cover:

•20 grams of carbohydrates in most young children (1 to 6 years of age)

•10 to 12 grams of carbohydrates in older prepubertal children

•8 to 10 grams in pubertal adolescents

Page 59: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 60: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 61: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 62: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 63: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 64: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 65: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 66: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 67: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 68: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 69: Dr Abdullah Alshaya Pediatric Endocrinologist

Hypoglycemic Reactions Hypoglycemic Reactions • Hypoglycemia is the major limitation to tight control of glucose levels. Once

injected, insulin absorption and action are independent of the glucose level,

thus creating a unique risk of hypoglycemia from an unbalanced insulin

effect. Insulin analogs may help reduce but cannot eliminate this risk.

• Most children with T1DM can expect mild hypoglycemia each week,

moderate hypoglycemia a few times each year, and severe hypoglycemia

every few years. These episodes are usually not predictable,

• although exercise, delayed meals or snacks, and wide swings in glucose

levels increase the risk.

Page 70: Dr Abdullah Alshaya Pediatric Endocrinologist

Infants and toddlers are at higher risk because they have more variable

meals and activity levels, are unable to recognize early signs of

hypoglycemia, and are limited in their ability to seek a source of oral

glucose to reverse the hypoglycemia.

The very young have an increased risk of permanently reduced cognitive

function as a long-term sequela of severe hypoglycemia. For this reason, a

more relaxed degree of glucose control is necessary until the child

matures

Hypoglycemia can occur at any time of day or night.

Page 71: Dr Abdullah Alshaya Pediatric Endocrinologist

Early symptoms and signs (mild hypoglycemia) may occur with a suddendecrease in blood glucose to levels that do not meet standard criteriaFor hypoglycemia in nondiabetic children.

The child may show pallor, sweating, apprehension or fussiness, hunger, tremor, and tachycardia, all due to the surge in catecholamines as thebody attempts to counter the excessive insulin effect. Behavioralchanges such as tearfulness, irritability, aggression, and naughtiness aremore prevalent in children.

Page 72: Dr Abdullah Alshaya Pediatric Endocrinologist

As glucose levels decline further, cerebral glucopenia occurs with drowsiness,

personality changes, mental confusion, and impaired judgment (moderate

hypoglycemia) progressing to inability to seek help and seizures or coma

(severe hypoglycemia). Prolonged severe hypoglycemia can result in a

depressed sensorium or Stroke like focal motor deficits that persist after the

hypoglycemia has resolved.

Although permanent sequelae are rare, severe hypoglycemia is frightening for

the child and family and can result in significant reluctance to attempt even

Moderate glycemic control afterward.

Page 73: Dr Abdullah Alshaya Pediatric Endocrinologist

• Recurrent hypoglycemic episodes associated with tight metabolic

control may aggravate partial counter-regulatory deficiencies,

producing a syndrome of hypoglycemia unawareness and reduced

ability to restore euglycemia (hypoglycemia-associated autonomic

failure). Avoidance of hypoglycemia allows some recovery from this

unawareness syndrome

Page 74: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 75: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 76: Dr Abdullah Alshaya Pediatric Endocrinologist

• The most important factors in the management of hypoglycemia are an understanding by the

patient and family of the symptoms and signs of the reaction and an anticipation of known

precipitating factors such as gym or sports activities. Tighter glucose control increases the risk.

• Families should be taught to look for typical hypoglycemic scenarios or patterns in the home

blood glucose log, so that they may adjust the insulin dose and avert predictable episodes.

• A source of emergency glucose should be available at all times and places, including at school

and during visits to friends. If possible, it is initially important to document the hypoglycemia

before treating, because some symptoms may not always be due to hypoglycemia.

• Most families and children develop a good sense for true hypoglycemic episodes and can

institute treatment before testing. Any child suspected of having a moderate to severe

hypoglycemic episode should also be treated before testing.

Page 77: Dr Abdullah Alshaya Pediatric Endocrinologist

• It is important not to give too much glucose; 5-10 g should be given

as juice or a sugar-containing carbonated beverage or candy, and

the blood glucose checked 15-20 minutes later. Patients, parents,

and teachers should also be instructed in the administration of

glucagon when the child cannot take glucose orally.

• An injection kit should be kept at home and school. The

intramuscular dose is 0.5 mg if the child weighs less than 20 kg and

1.0 mg if more than 20 kg. This produces a brief release of glucose

from the liver. Glucagon often causes emesis, which precludes

giving oral supplementation if the blood glucose declines after the

glucagon effects have waned. Caretakers must then be prepared to

take the child to the hospital for IV glucose administration,

Page 78: Dr Abdullah Alshaya Pediatric Endocrinologist

Dawn PhenomenonDawn Phenomenon• There are several reasons that blood glucose levels increase in the early morning

hours before breakfast. The most common is a simple decline in insulin levels and

is seen in many children using NPH or Lente as the basal insulin at supper or

bedtime. This usually results in routinely elevated morning glucose.

• The thought to be due mainly to overnight growth hormone secretion and

increased insulin clearance. It is a normal physiologic process seen in most

nondiabetic adolescents, who compensate with more insulin output. A child with

T1DM cannot compensate and may actually have declining insulin levels if using

evening NPH or Lente. The dawn phenomenon is usually recurrent and modestly

elevates most morning glucose levels.

Page 79: Dr Abdullah Alshaya Pediatric Endocrinologist

Somogyi phenomenonSomogyi phenomenon• Rarely, high morning glucose is due to the Somogyi

phenomenon, a theoretical rebound from late night or

early morning hypoglycemia, thought to be due to an

exaggerated counter-regulatory response.

• It is unlikely to be a common cause, in that most children

remain hypoglycemic (do not rebound) once nighttime

glucose levels decline. Continuous glucose monitoring

systems may help clarify ambiguously elevated morning

glucose levels.

Page 80: Dr Abdullah Alshaya Pediatric Endocrinologist

Management During Infections Management During Infections • Although infections are no more common in diabetic children than in nondiabetic

ones, they can often disrupt glucose control and may precipitate DKA.

• In addition, the diabetic child is at increased risk of dehydration if hyperglycemia

causes an osmotic diuresis or if ketosis causes emesis.

• Counter-regulatory hormones associated with stress blunt insulin action and

elevate glucose levels. If anorexia occurs, however, lack of caloric intake increases

the risk of hypoglycemia.

• Although children younger than 3 yr tend to become hypoglycemic and older

children tend toward hyperglycemia, the overall effect is unpredictable. Therefore,

frequent blood glucose monitoring and adjustment of insulin doses are essential

elements of sick day guidelines

Page 81: Dr Abdullah Alshaya Pediatric Endocrinologist

• The overall goals are to maintain hydration, control glucose levels, and avoid

ketoacidosis.

• This can usually be done at home if proper sick day guidelines are followed and

with telephone contact with health care providers. The family should seek advice if

home treatment does not control ketonuria, hyperglycemia, or hypoglycemia, or if

the child shows signs of dehydration.

• A child with large ketonuria and emesis should be seen in the emergency

department for a general examination, to evaluate hydration, and to determine

whether ketoacidosis is present by checking serum electrolytes, glucose, pH, and

total CO2.

• A child whose blood glucose declines to less than 50-60 mg/dL (2.8-3.3 mmol/L)

and who cannot maintain oral intake may need IV glucose, especially if further

insulin is needed to control ketonemia.

Page 82: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 83: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 84: Dr Abdullah Alshaya Pediatric Endocrinologist
Page 85: Dr Abdullah Alshaya Pediatric Endocrinologist